Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine pre-arthroplasty and perioperative opioid requirements
2005-003009-10Phase 4Completed
- Sponsor
- Barts Health NHS Trust
- Start
- Jun 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of buprenorphine in knee osteoarthritis (OA), hip osteoarthritis and osteoarthritis (OA) (2 arms), sponsored by Barts Health NHS Trust. Primary endpoint: Intraoperative opioid usage. Started Jun 2005; status: completed.
02
Drugs
buprenorphine
03
Conditions
knee osteoarthritis (OA)hip osteoarthritisosteoarthritis (OA)
Beyond the preview
Go deeper on 2005-003009-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003009-10.